Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Pfizer’s breast cancer drug gets EU approval

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …
News
novavax

Novavax cuts works force by a third in struggle to restructure

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
News
apps_mobile

Chinese FDA releases “drug scanner” app

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …
News
janssen_stairs

Collaboration on new therapeutic vaccine for HIV shows promise

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …
News

Pfizer to shut two out of three manufacturing plants in UK

November 9, 2016 Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …
News
amgen_hq

NICE turns down Amgen’s multiple myeloma drug

November 9, 2016 Research and Development, Sales and Marketing Amgen, Kyprolis, NICE

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …
News
valeant

Valeant’s tough year gets worse with Q3 loss of $1.22 billion

November 9, 2016 Research and Development Q3, Valeant, loss

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …
News
code

BenevolentAI announces licensing agreement with Janssen

November 8, 2016 Research and Development Janssen, Johnson & Johnson, artificial intelligence

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …
News
irina_antonijevic_image

Irina Antonijevic appointed as chief medical officer at vasopharm

November 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …
Appointment
cvnef_xxeaeoa4i

Free Pharmacovigilance Webinar: Only one day left to register!

November 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmacovigilance

There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …
News
biogen_austria_238

Biogen and Ionis’ spinal muscular atrophy drug meets primary endpoint

November 7, 2016 Manufacturing and Production, Research and Development Biogen, Ionis, spinal muscular atrophy

Biogen and Ionis Pharmaceuticals have released news that their investigational treatment for spinal muscular atrophy (SMA), Spinraza (nusinersen), met the …
News
banner_3

Free Pharmacovigilance Webinar: Just two days left to register!

November 7, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …
News
clinical_trials

Clinical trials and their patients: The rising costs and how to stem the loss

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials

The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …
Feature
nice_reception

NICE approves first new drug for breast cancer in a decade

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …
News
bernie_2

Lily increases diabetes drug by 700% over 20 years

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026